Discovery of a new BLT2 receptor antagonist for the treatment of inflammatory airway diseases
Dec. 7, 2023
Leukotriene B4 (LTB4) stimulates the release of cytokines and mediators that participate in tissue inflammation and acts as a chemoattractant for neutrophils, eosinophils and monocytes at the inflammation site.